Mer­ck sues Johns Hop­kins for li­cens­ing Keytru­da patents in se­cret and in con­flict with re­search col­lab­o­ra­tion

Mer­ck filed a law­suit against Johns Hop­kins Uni­ver­si­ty in Mary­land fed­er­al court on Tues­day, ar­gu­ing that the sto­ried uni­ver­si­ty ob­tained il­le­gal patents as part of its re­search col­lab­o­ra­tion with the com­pa­ny and re­lat­ed to its block­buster can­cer drug Keytru­da (pem­brolizum­ab).

Mer­ck al­leges that the Bal­ti­more-based uni­ver­si­ty ob­tained and li­censed Keytru­da-re­lat­ed patents in se­cret while claim­ing that Keytru­da was de­vel­oped be­fore and in­de­pen­dent of a 2013 re­search col­lab­o­ra­tion be­tween the two or­ga­ni­za­tions. Hop­kins al­so sought “hun­dreds of mil­lions of dol­lars” tied to Keytru­da sales be­cause of the patents, Mer­ck con­tends.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER